135 related articles for article (PubMed ID: 19391220)
1. Determination of EGFR status in gliomas: usefulness of immunohistochemistry and fluorescent in situ hybridization.
Guillaudeau A; Durand K; Pommepuy I; Robert S; Chaunavel A; Lacorre S; DeArmas R; Bourtoumieux S; El Demery M; Moreau JJ; Labrousse F
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):220-6. PubMed ID: 19391220
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy.
Marquez A; Wu R; Zhao J; Tao J; Shi Z
Diagn Mol Pathol; 2004 Mar; 13(1):1-8. PubMed ID: 15163002
[TBL] [Abstract][Full Text] [Related]
3. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
[TBL] [Abstract][Full Text] [Related]
4. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G
J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097
[TBL] [Abstract][Full Text] [Related]
5. Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas.
Zhao LL; Xu KL; Wang SW; Hu BL; Chen LR
Histopathology; 2012 Oct; 61(4):726-36. PubMed ID: 22978472
[TBL] [Abstract][Full Text] [Related]
6. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.
Waha A; Baumann A; Wolf HK; Fimmers R; Neumann J; Kindermann D; Astrahantseff K; Blümcke I; von Deimling A; Schlegel U
J Neurosurg; 1996 Oct; 85(4):634-41. PubMed ID: 8814167
[TBL] [Abstract][Full Text] [Related]
7. EGFR expression stratifies oligodendroglioma behavior.
Horbinski C; Hobbs J; Cieply K; Dacic S; Hamilton RL
Am J Pathol; 2011 Oct; 179(4):1638-44. PubMed ID: 21839716
[TBL] [Abstract][Full Text] [Related]
8. Expression of neu/c-erbB-2 in human brain tumors.
Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
[TBL] [Abstract][Full Text] [Related]
9. [Predictive molecular pathological testing in the diagnosis of high-grade tumors of glial origin].
Molnár P; Méhes G
Magy Onkol; 2009 Mar; 53(1):33-8. PubMed ID: 19318324
[TBL] [Abstract][Full Text] [Related]
10. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival.
Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.
Higgins RJ; Dickinson PJ; LeCouteur RA; Bollen AW; Wang H; Wang H; Corely LJ; Moore LM; Zang W; Fuller GN
J Neurooncol; 2010 May; 98(1):49-55. PubMed ID: 19967449
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.
Bredel M; Pollack IF; Hamilton RL; James CD
Clin Cancer Res; 1999 Jul; 5(7):1786-92. PubMed ID: 10430083
[TBL] [Abstract][Full Text] [Related]
13. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
14. HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Uehara T; Fujimoto M; Tsuruyama T; Date H; Haga H
Lung Cancer; 2014 Sep; 85(3):373-8. PubMed ID: 25047676
[TBL] [Abstract][Full Text] [Related]
15. Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain.
Guillaudeau A; Durand K; Rabinovitch-Chable H; Pommepuy I; Mesturoux L; Robert S; Chaunavel A; Moreau JJ; Labrousse F
Int J Oncol; 2012 Apr; 40(4):1142-52. PubMed ID: 22159595
[TBL] [Abstract][Full Text] [Related]
16. Assessment of EGFR and ERBB2 (HER2) in Gastric and Gastroesophageal Carcinomas: EGFR Amplification is Associated With a Worse Prognosis in Early Stage and Well to Moderately Differentiated Carcinoma.
Liao JB; Lee HP; Fu HT; Lee HS
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):374-382. PubMed ID: 27753660
[TBL] [Abstract][Full Text] [Related]
17. Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice.
Burel-Vandenbos F; Turchi L; Benchetrit M; Fontas E; Pedeutour Z; Rigau V; Almairac F; Ambrosetti D; Michiels JF; Virolle T
Neuro Oncol; 2013 Oct; 15(10):1278-88. PubMed ID: 23935154
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas.
Tabori U; Rienstein S; Dromi Y; Leider-Trejo L; Constantini S; Burstein Y; Dvir R; Amariglio N; Toren A; Rechavi G; Izraeli S; Aviram A
J Neurosurg; 2005 Oct; 103(4 Suppl):357-61. PubMed ID: 16270688
[TBL] [Abstract][Full Text] [Related]
19. EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization.
Wilcock DM; Goold E; Zuromski LM; Davidson C; Mao Q; Sirohi D
J Neuropathol Exp Neurol; 2024 Apr; 83(5):338-344. PubMed ID: 38605523
[TBL] [Abstract][Full Text] [Related]
20. Posterior fossa recurrence of WHO grade II and III supratentorial gliomas.
Terziev R; Petrirena G; Marie Y; Mueller WC; Bielle F; Delattre JY
Rev Neurol (Paris); 2018 Dec; 174(10):705-710. PubMed ID: 30314742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]